سعر جليبتس بلس 50/850 مجم 30 قرص 2024

Egyptian vildagliptin 50 mg / metformin 850 mg fixed-dose tablets (Gliptus plus, Eva Pharma).

• Vildagliptin is indicated for type 2 diabetes mellitus in combinations including with metformin per the Galvus SmPC; this Egyptian product is a vildagliptin/metformin FDC.Population: Adults with type 2 diabetes mellitusEuropean Medicines Agency (EMA)

• Vildagliptin: avoid in hepatic impairment (ALT/AST >3× ULN); metformin component adds lactic acidosis risk and renal dosing constraints.General active-ingredient information · European Medicines Agency (EMA), WHO Collaborating Centre for Drug Statistics Methodology (WHOCC) ATC/DDD Index

• Galvus should not be used during pregnancy or breast-feeding (vildagliptin component).General active-ingredient information · European Medicines Agency (EMA)

• Vildagliptin: Selective DPP-4 inhibitor increasing endogenous GLP-1 and GIP.
• Metformin hydrochloride: Decreases hepatic glucose production, decreases intestinal glucose absorption and improves insulin sensitivity by increasing peripheral glucose uptake and utilization; insulin secretion remains unchanged (US label).